Try our Advanced Search for more refined results
Life Sciences - July, 2011
165 articles
- Covidien Can't Evacuate FLSA Collective Action: Judge
- Fed. Circ. Affirms Lilly's Strattera Patent
- Judge Merges Shareholder Suits Over J&J FCPA Cases
- Fed. Circ. Rules Myriad Can Patent Breast Cancer Genes
- Pfizer Denied New Trial In $200M Neurontin MDL
- Allergan Hit With Off-Label Marketing FCA Suit
- FDA Should Scrap Moderate-Risk Review Process: Report
- J&J Cuts Maximum Tylenol Dose to Prevent Liver Damage
- Pfizer Hits Hetero With Suit Over Generic Viagra
- Pfizer, Others Not Liable For Gambling Addiction: 8th Circ.
- Pfizer Units Escape Suit Over Hormone Treatments
- Sen. Threatens To Hold Up FDA User Fee Renewal
- The Proper Care And Feeding Of Experts
- FDA Clarifies When Medical Device Changes Need Approval
- Ex-Taro Exec In Contempt Over $2M Insider Trading Fine
- AstraZeneca Settles Bulk Of Seroquel Diabetes Claims
- Medtronic Escapes Fraud Claims In Whistleblower Suit
- Fed. Circ. Won't Block Watson's Seasonique Generic
- Nelson Mullins Snags Pharma IP Expert
- Pfizer, Apotex To End Fight Over Generic Relpax
- AstraZeneca, Pozen Sue Lupin To Block Generic Vimovo
- ERX Incentive Program Changes — Too Little, Too Late?
- J&J Seeks Fed. Circ. Rehearing On Stent Patents
- Parsing Patent Term Extension In Europe
- Perrigo, Paddock Must Sell 6 Drugs In $540M Merger
- Pharma Cos. Fight Lilly Deposition Bid In Gemzar ITC Case
- DaVita Bilked Government For Wasted Kidney Drugs: Suit
- Astellas Stress Test Antitrust Suit Survives
- Trends In Qui Tam False Claims Cases
- Medco Investors Fight $29B Sale To Express Scripts
- CVS Pharmacists Denied Class Cert. In OT Action
- Judge Tosses Boehringer Workers' Wage-And-Hour Suit
- CDER Report Adds To New FDA Research Agenda
- Lupin, Medicis Reach Deal Over Generic Solodyn
- Obama Lays Out New Offensive Against Overseas Cartels
- Allos Investor Tries To Block $686M AMAG Merger
- Ky. Sues McKesson, First DataBank Over AWP Inflation
- Actos Needs Stronger Cancer Warnings: EU Regulator
- Synthes Targets Globus Over Spine Implant Patents
- Covington Reps Bristol-Myers In $325M Amira Buy
- 1st Circ. Revives FCA Claims In Amgen Kickback Suit
- $10M Suit Says Pfizer Failed To Warn Of Dilantin Effects
- Abbott Hits Hospira With Patent Suit Over Zemplar
- Great American Hits Pacific With Flood Coverage Suit
- Judge Swats Most Claims In Bug-Filled Similac Action
- FDA, EU Review Sanofi Heart Drug After Failed Trial
- InformedRx Sued Over Glucose Strip Expiration Dates
- Stiefel ERISA Plaintiffs Lose Class Cert. Bid
- Using The Anti-Injunction Act In Class Actions
- J&J Says Board Not To Blame For Recalls, Corruption Claims
- Bristol-Myers Settles AWP MDL Claims For $19M
- FTC Says Cardinal Health Must Sell Pharmacies
- Massey Sued By Respirator Co. In Black Lung Fight
- Fed. Circ. Says Teva Can't Block Cenestin Generic
- Novartis, Teva End Long-Running Lotrel Patent Suit
- Ropes & Gray Opens Shanghai Office
- Clear And Convincing Evidence In Invalidity Defense
- Medicis Seeks To Block Generic Loprox Shampoo
- Express Scripts' $29B Medco Buy To Face Antitrust Test
- Pay-For-Delay Ban Heads To Full Senate
- FDA Says Medical Device Reviews Must Be Streamlined
- Judge Pares Proskauer Tax Malpractice Suit
- Catalyst Sues Life Technologies Over DNA Sequencing IP
- Knobbe Martens Snags IP Atty For Silicon Valley Office
- Cooley, Latham Handle $686M AMAG-Allos Merger
- Using Consent Orders In Mass Tort Litigation
- Merck Fails To Nix Femina Birth Control Patent In ITC Row
- Ex-ArthroCare Exec Mostly Ducks $2.1M SEC Judgment
- Judge Tosses Deceptive Practices Claim In Seroquel Suit
- Zicam Inventor Admits Selling Unapproved Bird Flu Drug
- Aventis, Sun Settle Pair Of Allegra Generic Suits
- HGS Patent Suits Against Genentech Head To Calif.
- Improving The MSP Recovery Process
- False Marking Law Found Constitutional Again
- SEC Whistleblower Program Raises Privilege Worries
- NY Times Fires 1st In Webvention Data Patent Fight
- Lilly Again Sues APP Over Generic Alimta
- US Ends Prezista IP Suit Against Hetero Unit
- Ex-Rheingold Valet Partner Can Solicit Clients: Judge
- Hologic Triumphs In Mammogram Cushion IP Suit
- Suit Blames Diabetes Drug Byetta For Injuries, Deaths
- Q&A With Sheppard Mullin's Paul Garrity
- In Pursuit Of Individual Exclusions
- Amgen, Teva Settle Patent Suit Over Neopogen Generic
- General Dynamics Looks To Duck DataTern Patent Suit
- Shire Targets Mylan In Latest Suit Over Generic Vyvanse
- Bills Target OTC Drug Restriction On Health Accounts
- Skadden Reps Valeant In $345M Jannsen Unit Buy
- Contemplating Pliva V. Mensing
- Walgreen To Pay $3M Over Mass. Overbilling Claims
- Lupin Settles With Apotex Over Cholesterol Drug Patents
- Teva Drops Azilect Patent Claim Against Watson, Mylan
- Rite Aid Sues Ranbaxy Over Reglan Suit Indemnity
- Novartis Sales Reps File Suit Over Unpaid OT
- Orchid Shareholder Drops Suit Over $85M LabCorp Deal
- US Has No Immunity In Prezista Patent Case: Judge
- FDA Proposes Guidelines For Targeted Drug Therapies
- Judge Refuses To Toss Lead Counsel From Listerine MDL
- Tort Pro Joins Napoli Bern As Name Partner
- McDermott Nabs Ex-FTC Health Chief From Dechert
- Ill. Court Affirms $18M Verdict In Pain Patch Death
- Simpson Thacher Reps Apax In $6B Kinetic Concepts Deal
- FDA Warns Surgeons To Avoid Mesh Devices
- Ex-Nasdaq Exec Settles SEC Insider Trading Charges
- Boehringer Sales Rep Not Exempt From OT, Judge Says
- Prometheus: Bound For Clarification Or Confusion?
- Seattle Genetics Insider's Brother Pleads Guilty
- Biotronik Says CoStar Stent 'Recall' Violated Pact
- Astellas Settles Patent Suit Over Generic Adenoscan
- Winston Must Face Claims Over $56M Merger: Judge
- Braintree Ducks Indirect Purchasers' MiraLax Suit
- Reed Smith Opens In Shanghai With Dorsey Whitney Pro
- Edwards Angell Nabs MoFo IP Bigwig For NY Office
- Supreme Court Stacks Docket With IP Cases
- Translating India's New IT Law
- Feds Say Scios Mislabeled Heart Drug Natrecor
- Takeda, Mylan Reach Agreement Over Prevacid Generic
- Ex-Teva Scientist Testifies In Copaxone Patent Battle
- Perkins Coie Adds Patent Litigator in San Diego
- Medicare, Medicaid Sued Over Preferred Pharmacy Rule
- Nev. Court Won't Boot PDL BioPharma, Genentech Row
- High Court's IP Rulings In Rare Accord With Fed. Circ.
- Pfizer Targets Apotex In Fight To Block Generic Lyrica
- Jones Day Reps Sanofi In $425M Unit Sale To Valeant
- Purdue Targets Sandoz Over OxyContin Patents
- The Legal Duties Of Clinical Trial Sponsors
- Sandoz, Others Settle Medicaid Inflation MDL Suits
- Morgan Lewis Picks Up Jones Day Patent Pro
- Abbott Escapes Class Action Over Infested Similac
- Organon, Others Want $421M Medicaid FCA Suit Tossed
- Fed. Circ. Finds Respironics' Apnea Patents Invalid
- MarcTec Fights $5M Cordis Award In Fed. Circ.
- Fed. Circ. Overturns $5M RTI Win In Syringe IP Case
- Baker & McKenzie Adds Capital Pro In Beijing
- 4th Circ. Backs US In Medicaid Overbilling Row With W.Va.
- Watson Didn't Infringe Mucinex Patent: Fed. Circ.
- Teva Settles With Iowa In Wholesale Drug Suit
- Investor Hits BioMimetic With Fraud Action
- MiraLax Plaintiffs Win Injunction Against Braintree
- Wyeth Illegally Blocked Effexor XR Generics: Suit
- Don't Rock The Concord Boat
- J&J Suppressed Sales Of Cancer Test: Suit
- Pfizer Dodges More Sanctions In Neurontin Antitrust MDL
- Inyx Shareholders Win Class Cert. In Fraud Battle
- Shire Targets Roxane, Watson Over Generic Vyvanse
- DePuy, Calif. Co. Want Stryker Noncompete Deal Nixed
- FDA Bans Import Of Drugs From Dr. Reddy's Mexico Plant
- UK Court Favors Novartis In Lucentis Patent Suit
- Teva Asks Trial Judge To Dismiss Pfizer Viagra Suit
- Spotlight On Recent Preemption Decisions
- Boehringer Deal Leads EU Watchdog To Close Probe
- K&L Gates Adds Corporate Partners In Boston
- FDA Accuses Cadila Of Major Violations At India Plant
- EU Sees Drop In Pay-For-Delay Deals On Generics
- Barr Must Produce Docs In Provigil Pay-For-Delay Suit
- FDA Slams Zoll Over Defibrillator Battery Life Issues
- CareFusion To Pay $150M For Drug Dispenser Co. Rowa
- Actavis Settles Sanofi Suit Over Generic Allegra
- Study Ties Pfizer Anti-Smoking Drug To Heart Problems
- Ropes Reps TPG In $2B Bid To Take Immucor Private
- Shire Sues Sandoz, Amneal Over Vyvanse ANDA
- Ex-Stiefel Labs Exec Accuses Bosses Of $40M Con
- Depakote May Cause Cognitive Defects, FDA Warns
- Dog Owners Denied Class Cert. In ProMeris Suit
- A Bitter Pill For Brand Names?